PMID: 9177955Jan 1, 1997Paper

Psychopharmacoepidemiology in Iceland: effects of regulations and new medications

European Archives of Psychiatry and Clinical Neuroscience
T HelgasonH Tómasson

Abstract

The sale of psychotropic medications in Iceland has waxed and waned during the past 20 years with approximately 5 years between peak and bottom quantities sold. Apparently, it has decreased following restrictions imposed by the public health authorities and increased again following the introduction of new drug. In order to study this further, all prescriptions for psychotropic medications to non-hospitalized inhabitants of the capital city (Reykjavík) and dispensed by pharmacists there during 1 month in 1984, 1989 and 1993 were analysed in order to estimate the 1-month prevalence of psychopharmacological use. The results support the hypothesis partly as prescriptions for tranquillizers decreased in 1989 as well as the amount of tranquillizers and hypnotics prescribed following new restrictions, whereas the prevalence odds ratio of obtaining prescriptions for hypnotics remained unchanged. The proportion of patients receiving excessive amounts of tranquillizers and/or hypnotics decreased. The prevalence of excessive use of these drugs (i.e. > 90 DDD/month) was 0.5% in 1993. In 1993 the prevalence of the use of antidepressants as well as the amount prescribed had increased substantially following the introduction of the new selec...Continue Reading

References

Feb 1, 1976·Acta Psychiatrica Scandinavica·K Fruensgaard
Jan 1, 1992·Pharmacology & Therapeutics·J A Pratt
Nov 6, 1991·JAMA : the Journal of the American Medical Association·M WeintraubL Guttmacher
Jan 1, 1989·Social Science & Medicine·G Loomes, L McKenzie
Mar 1, 1985·Archives of General Psychiatry·G D MellingerE H Uhlenhuth
May 1, 1986·Acta Psychiatrica Scandinavica·C Allgulander
Jan 1, 1988·European Journal of Clinical Pharmacology·L Nolan, K O'Malley
Dec 1, 1988·Archives of General Psychiatry·R S BeardsleyJ Hidalgo
Aug 27, 1987·The New England Journal of Medicine·S B SoumeraiS Gortmaker
Jun 1, 1987·Journal of Epidemiology and Community Health·H ZuraykM Deeb
Jan 1, 1973·Acta Psychiatrica Scandinavica·L CoviE H Uhlenhuth
Dec 1, 1980·Journal of Epidemiology and Community Health·O OlafssonA Grímsson
Aug 11, 1983·The New England Journal of Medicine·D J GreenblattD R Abernethy
Jan 1, 1984·International Journal of Health Services : Planning, Administration, Evaluation·J B Kelley
Jan 1, 1981·British Journal of Addiction·H Petursson, M H Lader
Jan 1, 1993·Journal of Psychiatric Research·E H UhlenhuthG D Mellinger
Feb 2, 1994·JAMA : the Journal of the American Medical Association·R I ShorrW A Ray
Nov 1, 1995·Acta Psychiatrica Scandinavica·M JoukamaaV Lehtinen
Apr 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·M HotopfC Normand
Nov 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·K BingeforsK Wicknertz

❮ Previous
Next ❯

Citations

Feb 24, 2001·The New England Journal of Medicine·E Arnason
Feb 1, 2008·Nordic Journal of Psychiatry·Kristinn TómassonTómas Helgason

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.